Fairtree资产管理公司和其他公司购买了Bristol-Myers Squibb股票,因为股票比预期的收益要高。 Fairtree Asset Management and other firms bought Bristol-Myers Squibb stock after it beat earnings expectations.

Fairtree资产管理公司购买了价值550 000美元的Bristol-Myers Squibb(BMY)股票,其他公司如Anchor Pointe财富管理公司也增加了其持有量。 Fairtree Asset Management bought $550,000 worth of Bristol-Myers Squibb (BMY) stock, and other firms like Anchor Pointe Wealth Management also increased their holdings. Bristol-Myers Squibbb击败了对收入的预期,报告的EPS为1,80美元,而估计数为1,50美元。 Bristol-Myers Squibb beat earnings expectations, reporting $1.80 EPS compared to estimates of $1.50. 尽管净利润为18.53%,但该公司的股本回报率为13.93%,红利收益率为5.29%。 Despite a negative net margin of 18.53%, the company has a positive return on equity of 13.93% and offers a 5.29% dividend yield. 股市上限为953.4亿美元,具有“稳住”共识评级。 The stock's market cap is $95.34 billion with a "Hold" consensus rating.